Skip to main content
. 2020 Mar 17;18:130. doi: 10.1186/s12967-020-02282-3

Table 1.

Demographic and clinical characteristics of the study population

Characteristic HC (n = 12) Value for cohort (na)b or statistic p valuec
KSD-NTN (n = 12) KSD-pHTN (n = 11) KSD-HTN (n = 27)
Male [no. (%)] 9 (75.00) 6 (50.00) 4 (36.00) 23 (85.10) 0.013
Married status [no. (%)] 12 (100.00) 12 (100.00) 11 (100.00) 27 (100.00) 1.000
Age 58.91 ± 18.97 47.33 ± 14.95 54.09 ± 13.03 54.74 ± 12.36 0.270
Body mass index (kg/m2) 25.08 ± 3.33 22.67 ± 2.13 24.38 ± 1.69 25.82 ± 2.80 0.011
History of drinking 0 (0.00) 1 (8.33) 2 (18.18) 1 (3.70) 0.291
History of smoking 0 (0.00) 1 (8.33) 1 (9.09) 4 (14.81) 0.546
Urinary tract infection in previous 1 month 0 (0.00) 1 (8.33) 0 (0.00) 0 (0.00) 0.340
Duration of stones (years) 0.375
 < 0.5 year [no. (%)] NA 11 (91.67) 10 (90.91) 25 (92.59)
 0.5 to 1 year [no. (%)] NA 1 (8.33) 1 (9.09) 0 (0.00)
 > 1 year [no. (%)] NA 0 (0.00) 0 (0.00) 2 (7.41)
Duration of hypertension (years) NA NA NA 4.48 ± 4.59 NA
Systolic blood pressure (mmHg) 121.83 ± 5.52 113.58 ± 8.35 131.45 ± 7.46 151.11 ± 9.68 0.000
Diastolic blood pressure (mmHg) 74.92 ± 7.79 70.33 ± 4.64 80.64 ± 7.06 92.00 ± 9.74 0.000
Comorbidities
 Type 2 diabetic mellitus [no. (%)] 0 1 (8.33) 4 (36.36) 5 (18.52) 0.055
 Coronary heart disease [no. (%)] 0 0 (0.00) 0 (0.00) 2 (7.41) 0.332
Serum creatinine (μmol/L) 68.90 ± 10.77 72.89 ± 21.90 73.78 ± 28.80 93.56 ± 40.36 0.069
Blood urea nitrogen (mmol/L) 5.75 ± 1.61 5.75 ± 1.14 5.06 ± 1.43 6.20 ± 2.25 0.387
Estimated glomerular filtration rate (mL/min/1.73 m2) 97.45 ± 13.96 95.58 ± 20.95 89.91 ± 21.80 82.89 ± 26.19 0.209
Urinary pH 6.34 ± 0.65 6.38 ± 0.88 5.77 ± 0.82 6.39 ± 1.12 0.314

HC healthy controls, HTN hypertension, KSD kidney stone disease, NA not applicable, NTN normotension, pHTN pre-hypertension

an, no. of subjects

bMean ± SD or no. (%)

cFisher’s exact test was used for categorical variables and one-way analysis of variance was used to compare continuous variables